These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 32589691)

  • 61. A Retrospective Study of the C-Reactive Protein to Lymphocyte Ratio and Disease Severity in 108 Patients with Early COVID-19 Pneumonia from January to March 2020 in Wuhan, China.
    Yang M; Chen X; Xu Y
    Med Sci Monit; 2020 Sep; 26():e926393. PubMed ID: 32914767
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trial.
    Lyngbakken MN; Berdal JE; Eskesen A; Kvale D; Olsen IC; Rangberg A; Jonassen CM; Omland T; Røsjø H; Dalgard O
    Trials; 2020 Jun; 21(1):485. PubMed ID: 32503662
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Clinical analysis of 31 cases of 2019 novel coronavirus infection in children from six provinces (autonomous region) of northern China].
    Wang D; Ju XL; Xie F; Lu Y; Li FY; Huang HH; Fang XL; Li YJ; Wang JY; Yi B; Yue JX; Wang J; Wang LX; Li B; Wang Y; Qiu BP; Zhou ZY; Li KL; Sun JH; Liu XG; Li GD; Wang YJ; Cao AH; Chen YN
    Zhonghua Er Ke Za Zhi; 2020 Apr; 58(4):269-274. PubMed ID: 32118389
    [No Abstract]   [Full Text] [Related]  

  • 64. Risk factors for severe cases of COVID-19: a retrospective cohort study.
    He F; Luo Q; Lei M; Fan L; Shao X; Huang G; Zeng J; Zhao Z; Qin S; Yang Z; Yu N; Yang L; Cao J
    Aging (Albany NY); 2020 Aug; 12(15):15730-15740. PubMed ID: 32805730
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Clinical Characteristics of Patients with Severe Pneumonia Caused by the SARS-CoV-2 in Wuhan, China.
    Wang Y; Zhou Y; Yang Z; Xia D; Hu Y; Geng S
    Respiration; 2020; 99(8):649-657. PubMed ID: 32841948
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Clinical characteristics and risk factors of liver injury in COVID-19: a retrospective cohort study from Wuhan, China.
    Wang M; Yan W; Qi W; Wu D; Zhu L; Li W; Wang X; Ma K; Ni M; Xu D; Wang H; Chen G; Yu H; Ding H; Xing M; Han M; Luo X; Chen T; Guo W; Xi D; Ning Q
    Hepatol Int; 2020 Sep; 14(5):723-732. PubMed ID: 33026573
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms.
    Jin X; Lian JS; Hu JH; Gao J; Zheng L; Zhang YM; Hao SR; Jia HY; Cai H; Zhang XL; Yu GD; Xu KJ; Wang XY; Gu JQ; Zhang SY; Ye CY; Jin CL; Lu YF; Yu X; Yu XP; Huang JR; Xu KL; Ni Q; Yu CB; Zhu B; Li YT; Liu J; Zhao H; Zhang X; Yu L; Guo YZ; Su JW; Tao JJ; Lang GJ; Wu XX; Wu WR; Qv TT; Xiang DR; Yi P; Shi D; Chen Y; Ren Y; Qiu YQ; Li LJ; Sheng J; Yang Y
    Gut; 2020 Jun; 69(6):1002-1009. PubMed ID: 32213556
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Clinical characteristics of 194 cases of COVID-19 in Huanggang and Taian, China.
    Zhang H; Shang W; Liu Q; Zhang X; Zheng M; Yue M
    Infection; 2020 Oct; 48(5):687-694. PubMed ID: 32390091
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Clinical characteristics of different subtypes and risk factors for the severity of illness in patients with COVID-19 in Zhejiang, China.
    Zhang SY; Lian JS; Hu JH; Zhang XL; Lu YF; Cai H; Gu JQ; Ye CY; Jin CL; Yu GD; Jia HY; Zhang YM; Sheng JF; Li LJ; Yang YD
    Infect Dis Poverty; 2020 Jul; 9(1):85. PubMed ID: 32641121
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Clinical characteristics and risk factors for liver injury in COVID-19 patients in Wuhan.
    Zhang H; Liao YS; Gong J; Liu J; Zhang H
    World J Gastroenterol; 2020 Aug; 26(31):4694-4702. PubMed ID: 32884226
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A prospective, randomised, double blind placebo-controlled trial to evaluate the efficacy and safety of tocilizumab in patients with severe COVID-19 pneumonia (TOC-COVID): A structured summary of a study protocol for a randomised controlled trial.
    Rilinger J; Kern WV; Duerschmied D; Supady A; Bode C; Staudacher DL; Wengenmayer T
    Trials; 2020 Jun; 21(1):470. PubMed ID: 32493514
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Clinical Characteristics and Predictors of Disease Progression in Severe Patients with COVID-19 Infection in Jiangsu Province, China: A Descriptive Study.
    Huang M; Yang Y; Shang F; Zheng Y; Zhao W; Luo L; Han X; Lin A; Zhao H; Gu Q; Shi Y; Li J; Xu X; Liu K; Deng Y; Cao Q; Wang W
    Am J Med Sci; 2020 Aug; 360(2):120-128. PubMed ID: 32709280
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Analysis of clinical characteristics and outcomes in patients with COVID-19 based on a series of 1000 patients treated in Spanish emergency departments.
    Gil-Rodrigo A; Miró Ò; Piñera P; Burillo-Putze G; Jiménez S; Martín A; Martín-Sánchez FJ; Jacob J; Guardiola JM; García-Lamberechts EJ; Espinosa B; Martín Mojarro E; González Tejera M; Serrano L; Agüera C; Soy E; Llauger L; Juan MÁ; Palau A; Del Arco C; Rodríguez Miranda B; Maza Vera MT; Martín Quirós A; Tejada de Los Santos L; Ruiz de Lobera N; Iglesias Vela M; Torres Garate R; Alquézar-Arbé A; González Del Castillo J; Llorens P;
    Emergencias; 2020 Ago; 32(4):233-241. PubMed ID: 32692000
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Clinical Features of Coronavirus Disease 2019 Patients With Mechanical Ventilation: A Nationwide Study in China.
    Wang T; Tang C; Chen R; Ruan H; Liang W; Guan W; Sang L; Tang R; Zhong N; Li S
    Crit Care Med; 2020 Sep; 48(9):e809-e812. PubMed ID: 32618693
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Safety and efficacy assessment of allogeneic human dental pulp stem cells to treat patients with severe COVID-19: structured summary of a study protocol for a randomized controlled trial (Phase I / II).
    Ye Q; Wang H; Xia X; Zhou C; Liu Z; Xia ZE; Zhang Z; Zhao Y; Yehenala J; Wang S; Zhou G; Hu K; Wu B; Wu CT; Wang S; He Y
    Trials; 2020 Jun; 21(1):520. PubMed ID: 32532356
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Clinical Characteristics, Associated Factors, and Predicting COVID-19 Mortality Risk: A Retrospective Study in Wuhan, China.
    Yu C; Lei Q; Li W; Wang X; Liu W; Fan X; Li W
    Am J Prev Med; 2020 Aug; 59(2):168-175. PubMed ID: 32564974
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Clinical features of familial clustering in patients infected with 2019 novel coronavirus in Wuhan, China.
    Li J; Gong X; Wang Z; Chen R; Li T; Zeng D; Li M
    Virus Res; 2020 Sep; 286():198043. PubMed ID: 32502551
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Clinical characteristics and factors affecting the duration of positive nucleic acid test for patients of COVID-19 in XinYu, China.
    Lu J; Yin Q; Li Q; Fu G; Hu X; Huang J; Chen L; Li Q; Guo Z
    J Clin Lab Anal; 2020 Oct; 34(10):e23534. PubMed ID: 32860649
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Application of ordinal logistic regression analysis to identify the determinants of illness severity of COVID-19 in China.
    Xu K; Zhou M; Yang D; Ling Y; Liu K; Bai T; Cheng Z; Li J
    Epidemiol Infect; 2020 Jul; 148():e146. PubMed ID: 32631458
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Monitoring and Management of Home-Quarantined Patients With COVID-19 Using a WeChat-Based Telemedicine System: Retrospective Cohort Study.
    Xu H; Huang S; Qiu C; Liu S; Deng J; Jiao B; Tan X; Ai L; Xiao Y; Belliato M; Yan L
    J Med Internet Res; 2020 Jul; 22(7):e19514. PubMed ID: 32568727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.